Effect of aspirin on single and multiple dose pharmacokinetics of ciprofloxacin in rabbits

Indian Journal of Pharmacology

Volumn 28, Issue 1, 1996, Pages 25-28

  Parikh, V ^a,c   Shivprakash, ^b   Patel, D ^b   Gandhi, T P ^b   Patel, R B ^b   Santani, D D ^a  

^a L M COLLEGE OF PHARMACY   (India)

^b Cadila Pharmaceuticals Limited   (India)

^c PUNJABI UNIVERSITY   (India)

Author keywords

aspirin; ciprofloxacin; clearance; drug interaction; elimination; pharmacokinetic parameters

Indexed keywords

ACETYLSALICYLIC ACID; CIPROFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RABBIT;

EID: 0029874663     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ministry of Health and Welfare. Information on drug adverse reactions, Tokyo. 1986;81:1-2.
2. Ministry of Health and Welfare. Information on drug adverse reactions, Tokyo, 1989;98:2-3.
3. Hirai S, Tanaka K, Makine S, Narita H. Adverse drug interaction between pyridone carboxylic acids and nonsteroidal anti-inflammatory drugs: convulsions after oral or intracerebral administration in mice. Yakugaku Zasshi 1989;109:119-26.
4. Naora K, Katagiri Y, Ichikawa N, Hayashibara M, Iwamoto K. Apossible reduction in the renal clearance of ciprofloxacin by fenbufen in rats. J Pharm Pharmacol 1990;42:704-7.
5. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcell Dekker Inc. 1982.
6. Bjornsson TD, Shand DG. Estimation of kinetic parameters from a two point determination of the drug cumulation factor. Clin Pharmacol Ther 1979;26:540-7.
7. Tartaglione TA, Raffalovich AC, Poyner WJ, Ingroff AE, Kerkering TM. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses. Antimicrob Agents Chemother 1986;28:62-6.
8. Hoffken G, Lode H, Pringin C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985; 27:375-9.
9. Siefert HM, Maruhn D, Maul W, Forster D, Ritter W. Pharmacokinetics of ciprofloxacin, 1st communication, absorption, concentration in plasma, metabolism and excretion after a single dose administration of (14C) ciprofloxacin in albino rats and rhesus monkey. Arz Forsh 1986;36:1417-20.
10. Drusano GL, Plaisance KI, Forrest A, Standiford HC. Dose ranging study and constant infusion evaluation of ciprofloxacin. Antimicrob Agents Chemother 1986; 30: 440-3.
11. Drusano GL, Weir M, Forrest A, Plaisance K, Standiford HC. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal functions. Antimicrob Agents Chemother 1987;31:860-4.
12. Borner K, Lode H, Hoffken G. Renal elimination of sulphociprofloxacin, a new metabolite of ciprofloxacin. Eur J Clin Microb 1986;5:476.
13. Wingender W, Beermann D, Forseter O, Grafe KH, Schacht P, Scharbrodt V. Mechanism of renal excretion of ciprofloxacin (Bay o 9867), a new quinolone carboxylic acid derivative, in humans. Abstract 4th Mediterranaen Congress of Chemotherapy. Rhodes, 1984.
14. Davison C. Salicylate metabolism in man. Ann N Y Acad Sci 1971;179:249-68.
15. Guggino SE, Martin GJ, Aronson PS. Specificity and modes of the anion exchange in dog renal microvillus membranes. Am J Physiol 1983;244:F612-21.